{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:52:07Z","timestamp":1793303527150,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,1,13]],"date-time":"2007-01-13T00:00:00Z","timestamp":1168646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2007,9,27]]},"DOI":"10.1007\/s10549-006-9456-9","type":"journal-article","created":{"date-parts":[[2007,1,16]],"date-time":"2007-01-16T14:10:14Z","timestamp":1168956614000},"page":"267-276","source":"Crossref","is-referenced-by-count":19,"title":["BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses"],"prefix":"10.1007","volume":"105","author":[{"given":"Antonio","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Cal\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Agnese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Corsale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Augello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Gargano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Cascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Intrivici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetana","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspare","family":"Gulotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Macaluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Surmacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Gebbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,13]]},"reference":[{"key":"9456_CR1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371","journal-title":"Science"},{"key":"9456_CR2","doi-asserted-by":"crossref","unstructured":"Ford D, Easton DF, Stratton M et al and Breast Cancer linkage Consortium (1998) Genetic heterogenicity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676\u2013689","DOI":"10.1086\/301749"},{"key":"9456_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng853","volume":"31","author":"PD Pharoah","year":"2002","unstructured":"Pharoah PD, Antoniou A, Bobrow M et al (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33\u201336","journal-title":"Nat Genet"},{"issue":"1","key":"9456_CR4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(96)01312-9","volume":"400","author":"I Callebaut","year":"1997","unstructured":"Callebaut I, Mornon JP. (1997) From BRCA1 to Rap1: a widespread BRCT module closely associated with DNA repair. FEBS Lett 400(1):25\u201330","journal-title":"FEBS Lett"},{"key":"9456_CR5","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"9418","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR, Calzone KA et al (2002) Cancer risk estimates for BRCA1 mutation carriers identif\u00eced in a risk evaluation program. J Natl Cancer Inst 9418:1365\u20131372","journal-title":"J Natl Cancer Inst"},{"key":"9456_CR6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT et al (1994) Breast Cancer Linkage Consortium. Lancet 343:692\u2013695","journal-title":"Lancet"},{"issue":"5","key":"9456_CR7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<744::AID-CNCR4>3.0.CO;2-G","volume":"86","author":"HT Lynch","year":"1999","unstructured":"Lynch HT, Watson P, Narod SA (1999) The genetic epidemiology of male breast carcinoma. Cancer 86(5):744\u2013746","journal-title":"Cancer"},{"key":"9456_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2003.10.005","volume":"2051","author":"A Nkondjock","year":"2004","unstructured":"Nkondjock A, Ghadirian P. (2004) Epidemiology of breast cancer among BRCA mutation carriers: an overview. Cancer Lett 2051:1\u20138","journal-title":"Cancer Lett"},{"key":"9456_CR9","first-page":"2998","volume":"55","author":"H Takahashi","year":"1995","unstructured":"Takahashi H, Behbakht K, McGovern PE et al (1995) Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 55:2998\u20133002","journal-title":"Cancer Res"},{"key":"9456_CR10","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1126\/science.306.5705.2187c","volume":"306","author":"DF Easton","year":"2004","unstructured":"Easton DF, Hopper JL, Thomas DC et al (2004) Breast cancer risks for BRCA1\/2 carriers. Science 306:2187\u20132188","journal-title":"Science"},{"issue":"5","key":"9456_CR11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"9456_CR12","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.ejhg.5201256","volume":"12","author":"F Marroni","year":"2004","unstructured":"Marroni F, Aretini P, D\u2019Andrea E et al (2004 )Penetrance of breast ad ovarian cancer in a large series of families tested for BRCA1\/2 mutations. Eur J Hum Genet 12:899\u2013906","journal-title":"Eur J Hum Genet"},{"key":"9456_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/annonc\/mdh651","volume":"15","author":"G Cipollini","year":"2004","unstructured":"Cipollini G, Tommasi S, Paradiso A et al (2004) Genetic alteration in hereditary breast cancer. Ann Oncol 15:7\u201313","journal-title":"Ann Oncol"},{"key":"9456_CR14","first-page":"1013","volume":"60","author":"CI Szabo","year":"1997","unstructured":"Szabo CI, King MC. (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013\u20131020","journal-title":"Am J Hum Genet"},{"key":"9456_CR15","first-page":"1041","volume":"60","author":"T Peelen","year":"1997","unstructured":"Peelen T, van Vliet M, Petrij-Bosch A et al (1997). A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60:1041\u20131049","journal-title":"Am J Hum Genet"},{"key":"9456_CR16","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/S0959-8049(01)00223-4","volume":"37","author":"Z Einbeigi","year":"2001","unstructured":"Einbeigi Z, Bergman A, Kindblom LG et al (2001) A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer. Eur J Cancer 37:1904\u20131909","journal-title":"Eur J Cancer"},{"key":"9456_CR17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1054\/bjoc.1999.0963","volume":"82","author":"M Pisano","year":"2000","unstructured":"Pisano M, Cossu A, Persico I et al (2000) Identification of a founder BRCA2 mutation in Sardinia. Br J Cancer 82:553\u2013559","journal-title":"Br J Cancer"},{"key":"9456_CR18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/humu.1167","volume":"18","author":"F Baudi","year":"2001","unstructured":"Baudi F, Quaresima B, Grandinetti C et al (2001)Evidence of a founder mutation of BRCA1 gene in a highly homogeneous population from southern Italy with breast\/ ovarian cancer. Hum Mut 18:163\u2013164","journal-title":"Hum Mut"},{"key":"9456_CR19","unstructured":"Breast Cancer Information Core (BIC) (2002) An open access on line breast cancer mutation database. Retrived from http:\/\/www.hhgri.nih.gov\/Intramural_transfer\/Bic\/"},{"key":"9456_CR20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mrfmmm.2004.07.024","volume":"573","author":"T Judkins","year":"2005","unstructured":"Judkins T, Hendrickson BC, Deffenbaugh MA et al (2005) Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1. Mut Res 573:168\u2013179","journal-title":"Mut Res"},{"key":"9456_CR21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/424388","volume":"75","author":"DE Goldgard","year":"2004","unstructured":"Goldgard DE, Easton DF, Deffenbaugh AM et al (2004) Breast Cancer Information Core (BIC) Sterring Committee. Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75:535\u2013544","journal-title":"Am J Hum Genet"},{"key":"9456_CR22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/424388","volume":"75","author":"CM Phelan","year":"2004","unstructured":"Phelan CM, Dapic V, Tice B et al (2004) Classification of BRCA1 missense variants of unknown clinical significance. Am J Hum Genet 75:535\u2013544","journal-title":"Am J Hum Genet"},{"key":"9456_CR23","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1200\/JCO.1996.14.5.1730","volume":"14","author":"ASCO","year":"1996","unstructured":"ASCO (1996) Statement of the American Society of Clinical Oncology, genetic testing for cancer susceptibility, Adopted on Febbruary 20, 1996. J Clin Oncol 14:1730\u20131740","journal-title":"J Clin Oncol"},{"key":"9456_CR24","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2003.03.189","volume":"21","author":"ASCO","year":"2003","unstructured":"ASCO (2003) American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21:2397\u20132406","journal-title":"J Clin Oncol"},{"key":"9456_CR25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1294-399","volume":"8","author":"LS Friedman","year":"1994","unstructured":"Friedman LS, Ostermeyer EA, Szabo CI et al (1994) Confirmation of BRCA 1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8:399\u2013404","journal-title":"Nat Genet"},{"key":"9456_CR26","first-page":"1483","volume":"13","author":"MA Caligo","year":"1996","unstructured":"Caligo MA, Ghimenti C, Cipollini G et al (1996) BRCA1 germline mutation spectrum in Italian families from Tuscany: a high frequency of novel mutations. Oncogene 13:1483\u20131488.","journal-title":"Oncogene"},{"issue":"1","key":"9456_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<1::AID-HUMU1>3.0.CO;2-O","volume":"11","author":"SE Antonarakis","year":"1998","unstructured":"Antonarakis SE. (1998) Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 11(1):1\u20133","journal-title":"Hum Mutat"},{"issue":"3","key":"9456_CR28","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jcp.20601","volume":"207","author":"C Augello","year":"2006","unstructured":"Augello C, Gregorio V, Bazan V et al (2006) TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. J Cell Physiol Jun 207(3):654\u2013659","journal-title":"J Cell Physiol Jun"},{"key":"9456_CR29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/bcr72","volume":"2","author":"L Ottini","year":"2000","unstructured":"Ottini L, D\u2019Amico C, Noviello C et al (2000) BRCA1 and BRCA2 mutations in central and southern Italian patients. Breast Cancer Res 2:307\u2013310","journal-title":"Breast Cancer Res"},{"key":"9456_CR30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<130::AID-GCC3>3.0.CO;2-U","volume":"27","author":"L Cortesi","year":"2000","unstructured":"Cortesi L, Turchetti D, Bertoni C, et al (2000) Comparison between genotype and phenotype identifies a high-risk population carryng BRCA1 mutations. Genes Chromosomes Cancer 27:130\u2013135","journal-title":"Genes Chromosomes Cancer"},{"key":"9456_CR31","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0959-8049(00)00287-2","volume":"36","author":"D Turchetti","year":"2000","unstructured":"Turchetti D, Cortesi L, Federico M et al (2000) BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer. Eur J Cancer 36:2083\u20132089","journal-title":"Eur J Cancer"},{"key":"9456_CR32","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jama.279.12.922","volume":"279","author":"KE Malone","year":"1998","unstructured":"Malone KE, Daling JR, Thompson JD et al (1998) BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before 45 years with first-degree family hystory. J Am Med Assoc 279:922\u2013929","journal-title":"J Am Med Assoc"},{"issue":"7","key":"9456_CR33","doi-asserted-by":"crossref","first-page":"vii34","DOI":"10.1093\/annonc\/mdl947","volume":"17","author":"C Capalbo","year":"2006","unstructured":"Capalbo C, Ricevuto E, Vestri A et al (2006) BRCA1 and BRCA2 genetic testing in Italian breast and\/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models. Ann Oncol; 17(7):vii34\u2013vii40","journal-title":"Ann Oncol;"},{"key":"9456_CR34","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejca.2003.09.016","volume":"40","author":"S Malander","year":"2004","unstructured":"Malander S, Ridderheim M, Masback A et al (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40:422\u2013428","journal-title":"Eur J Cancer"},{"key":"9456_CR35","first-page":"3663","volume":"56","author":"G Johannesdottir","year":"1996","unstructured":"Johannesdottir G, Gudmundsson J, Bergthorsson JT et al (1996) High prevalence of the 999del5 mutation in Icelandic breast cancer patients. Cancer Res 56:3663\u20133665","journal-title":"Cancer Res"},{"key":"9456_CR36","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1086\/302678","volume":"65","author":"JP Struewing","year":"1999","unstructured":"Struewing JP, Coriaty ZM, Ron E et al (1999) Founder BRCA1\/2mutations among male patients with breast cancer in Israel. Am J Hum Genet 65:1800\u20131802","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9456_CR37","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/bcr419","volume":"4","author":"VM Basham","year":"2002","unstructured":"Basham VM, Lipscombe JM, Ward JM et al (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 4(1):R2","journal-title":"Breast Cancer Res"},{"key":"9456_CR38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ijc.1627","volume":"97","author":"M La Hoya De","year":"2002","unstructured":"De La Hoya M, Osorio A, Godino J et al (2002) Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: implications for genetic testing. Int J Cancer 97:466\u2013471","journal-title":"Int J Cancer"},{"key":"9456_CR39","first-page":"342","volume":"63","author":"L Ottini","year":"2003","unstructured":"Ottini L, Masala G, D\u2019Amico C et al (2003) BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 63:342\u2013347","journal-title":"Cancer Res"},{"key":"9456_CR40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/B:BREA.0000021049.61839.e5","volume":"85","author":"PTC Iau","year":"2004","unstructured":"Iau PTC, M. Marafie A. Ali et al (2004) Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer. Breast Cancer Res Treatment 85:81\u201388","journal-title":"Breast Cancer Res Treatment"},{"key":"9456_CR41","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/sj.onc.1202106","volume":"17","author":"T Crook","year":"1998","unstructured":"Crook T, Brooks LA, Crossland S et al (1998) P53 mutations with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2- associated breast tumours. Oncogene 17:1682\u20131689","journal-title":"Oncogene"},{"key":"9456_CR42","first-page":"1588","volume":"58","author":"F Eisinger","year":"1998","unstructured":"Eisinger F, Jacquemier J, Charpin C et al (1998) Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res 58:1588\u20131592","journal-title":"Cancer Res"},{"key":"9456_CR43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00439-005-1297-9","volume":"117","author":"H Vezina","year":"2005","unstructured":"Vezina H, Durocher F, Dumont M et al (2005) Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast-ovarian cancer families. Hum Genet 117:119\u2013132","journal-title":"Hum Genet"},{"key":"9456_CR44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/B:FAME.0000026819.44213.df","volume":"3","author":"D Muller","year":"2004","unstructured":"Muller D, Bonaiti-Pellie C, Abecassis J et al (2004) BRCA1 testing in breast ad\/or ovarian cancer families from north-eastern France identifies two common mutations with a founder effect. Familial Cancer 3:15\u201320","journal-title":"Familial Cancer"},{"key":"9456_CR45","first-page":"1","volume":"22","author":"V Calo","year":"2005","unstructured":"Calo V, Agnese V, Gargano G et al (2005) A new germline mutation in a Sicilian family with ovarian cancer. Breast Cancer Res Treat 22:1\u20134","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"9456_CR46","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/hmg\/ddi476","volume":"15","author":"JR Morris","year":"2006","unstructured":"Morris JR, Pangon L, Boutell C et al (2006) Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility. Human Mol Genet 15(4):599\u2013606","journal-title":"Human Mol Genet"},{"issue":"3","key":"9456_CR47","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1073\/pnas.0237285100","volume":"100","author":"MA Fleming","year":"2003","unstructured":"Fleming MA, Potter JD, Ramirez CJ et al (2003) Understanding missense mutations in the BRCA1 gene: An evolutionary approach. PNAS 100(3):1151\u20131156","journal-title":"PNAS"},{"key":"9456_CR48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jmg.2003.015867","volume":"41","author":"V Abkevich","year":"2004","unstructured":"Abkevich V, Zharkikh A, Deffenbaugh AM et al (2004) Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet 41: 492\u2013507","journal-title":"J Med Genet"},{"issue":"Suppl 7","key":"9456_CR49","doi-asserted-by":"crossref","first-page":"vii30","DOI":"10.1093\/annonc\/mdl946","volume":"17","author":"C Augello","year":"2006","unstructured":"Augello C, Bruno L, Bazan V et al (2006) Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell\u2019Italia Meridionale) prospective study. Ann Oncol 17(Suppl 7):vii30\u2013vii33","journal-title":"Ann Oncol"},{"key":"9456_CR50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jmg.2005.033878","volume":"43","author":"SV Tavtigian","year":"2006","unstructured":"Tavtigian SV, Deffenbaugh AM, Yin L et al (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43:295\u2013305","journal-title":"J Med Genet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9456-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-006-9456-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9456-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:28:47Z","timestamp":1559219327000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-006-9456-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,13]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9,27]]}},"alternative-id":["9456"],"URL":"https:\/\/doi.org\/10.1007\/s10549-006-9456-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,13]]}}}